首页 > 最新文献

Innovative Surgical Sciences最新文献

英文 中文
Paradox inflammatory reaction such as appendicitis epiploica and diverticulitis of the sigmoid colon under ongoing immunosuppression after previous liver transplantation (LTx) 先前肝移植(LTx)后持续免疫抑制的乙状结肠阑尾炎、网膜和憩室炎等矛盾炎症反应
Q2 SURGERY Pub Date : 2023-09-15 DOI: 10.1515/iss-2023-0038
Isabella Trautwein, Manuela Petersen, Christine March, Roland S. Croner, Frank Meyer
Abstract Objective Inflammatory reactions caused by immunosuppression appear a particular interesting disease due to its very specific and partly unclear etiopathogenesis. Based on clinical case-specific management experiences and selective references from the literature, the rare case of an acute intraabdominal inflammation as unusual complication or side effect (at the gastrointestinal [GI] tract) of the ongoing immunosuppressive medication using Mycophenolate mofetil and Tacrolimus after previous liver transplantation is to be illustrated. Case presentation Medical history ( hx ): 1) Current : A 68-years old male patient underwent abdominal CT scan because of pain in the left lower abdomen with the suspicious diagnosis of diverticulitis leading to initiation of antibiotic therapy 24 h prior to the transferral to the own hospital for adequate liver transplantation (LTx) follow-up investigation. 2) Medication contained Sitagliptin 1 × 100 mg, Omeprazol 1 × 40 mg, Mesalazin 500 mg 3 × 2, Movicol 1 (on demand), Mycophenolate mofetil 2 × 500 mg, Tacrolimus 2 × 1 mg and Hydrochlorothiazid 1 × 2.5 mg. 3) Additional diagnoses included arterial hypertension, diabetes mellitus and urinary bladder diverticle. 4) Previous surgical intervention profile comprises resection of liver segments IV/V due to HCC (2011), orthotopic liver transplantation because of HCC caused by alcohol-induced liver cirrhosis (2013) and an intervertebral disc operation (2018). Physical examination of the abdomen revealed marked tenderness in the lower left quadrant. The abdominal wall was soft and there were no defensive tension and no peritonism. The patient was in good general condition and nutritional status. He was cardiopulmonarily stable and oriented to all qualities. Diagnostic measures showed a CRP of 38.0 (normal range, < 5) mg/L and a white blood cell count within normal range. Leading diagnoses were found using abdominal CT scan, which demonstrated an extended diverticulosis and an appendicitis epiploica within the immediate subperitoneal region of the left lower abdomen with an oval fat isodense structure in the region of the sigmoid colon with surrounding inflammatory imbibition and pronounced intestinal wall. Suspicious diagnosis was the 1st episode of an uncomplicated diverticulitis of the sigmoid colon associated with an appendicitis epiploica. Therapeutic approach was given by conservative therapy with infusion therapy, analgesia as well as inital “n. p. o.” and following initiation of oral nutrition. In addition, calculated antibiotic therapy with Cefuroxime and Clont was initiated. Clinical course was uneventful, with discharge on the eighth day of hospital stay with no pathological findings and substantial improvement in clinical and laboratory findings. Further advice consisted of clinical and laboratory follow-up control investigations by the family practitioner and nutritional counselling. In addition, a colonoscopy should be performed within four months. Co
摘要目的免疫抑制引起的炎症反应是一种特别有趣的疾病,由于其非常特异性和部分不明确的病因。根据临床病例特异性管理经验和文献的选择性参考,我们将对既往肝移植后持续使用霉酚酸酯和他克莫司进行免疫抑制治疗而出现急性腹内炎症的罕见病例(胃肠道)进行说明。病例介绍病史(hx): 1)目前:68岁男性患者,因左下腹疼痛,可疑诊断为憩室炎,24小时前接受腹部CT扫描,开始抗生素治疗,转到本院进行充分的肝移植(LTx)随访调查。2)药物:西格列汀1 × 100 mg,奥美拉唑1 × 40 mg,美沙拉嗪500 mg 3 × 2,莫维柯1(按需),霉酚酸酯2 × 500 mg,他克莫司2 × 1 mg,氢氯噻嗪1 × 2.5 mg。3)附加诊断包括动脉高血压、糖尿病、膀胱憩室。4)既往手术干预包括肝细胞癌IV/V节段切除(2011年)、酒精性肝硬化肝细胞癌原位肝移植(2013年)和椎间盘手术(2018年)。腹部体格检查显示左下腹明显压痛。腹壁柔软,无防御性张力,无腹胀。患者一般情况及营养状况良好。他的心肺状况稳定,一切素质都很好。诊断结果显示CRP为38.0(正常范围;5) mg/L,白细胞计数正常。主要诊断为腹部CT扫描,显示左侧下腹腹膜下区延伸憩室和阑尾炎,乙状结肠区呈椭圆形脂肪等致密结构,周围有炎症性吸胀和明显的肠壁。可疑的诊断是一个无并发症的乙状结肠憩室炎合并阑尾炎的第一次发作。治疗方法为保守治疗加输注、镇痛及初始治疗。p。o "然后开始口服营养。此外,计算抗生素治疗头孢呋辛和Clont开始。临床过程平淡无奇,住院第8天出院,无病理发现,临床和实验室检查有实质性改善。进一步的建议包括由家庭医生进行的临床和实验室随访对照调查以及营养咨询。此外,结肠镜检查应在四个月内进行。结论本病例可能是免疫抑制药物霉酚酸酯和他克莫司分别被列为“结肠炎症”和“胃肠道炎症”的众多副作用之一,也可能是移植相关免疫抑制药物引起的易感(胃)肠黏膜或整个肠壁对微生物或微生物颗粒或药物的炎症反应。
{"title":"Paradox inflammatory reaction such as appendicitis epiploica and diverticulitis of the sigmoid colon under ongoing immunosuppression after previous liver transplantation (LTx)","authors":"Isabella Trautwein, Manuela Petersen, Christine March, Roland S. Croner, Frank Meyer","doi":"10.1515/iss-2023-0038","DOIUrl":"https://doi.org/10.1515/iss-2023-0038","url":null,"abstract":"Abstract Objective Inflammatory reactions caused by immunosuppression appear a particular interesting disease due to its very specific and partly unclear etiopathogenesis. Based on clinical case-specific management experiences and selective references from the literature, the rare case of an acute intraabdominal inflammation as unusual complication or side effect (at the gastrointestinal [GI] tract) of the ongoing immunosuppressive medication using Mycophenolate mofetil and Tacrolimus after previous liver transplantation is to be illustrated. Case presentation Medical history ( hx ): 1) Current : A 68-years old male patient underwent abdominal CT scan because of pain in the left lower abdomen with the suspicious diagnosis of diverticulitis leading to initiation of antibiotic therapy 24 h prior to the transferral to the own hospital for adequate liver transplantation (LTx) follow-up investigation. 2) Medication contained Sitagliptin 1 × 100 mg, Omeprazol 1 × 40 mg, Mesalazin 500 mg 3 × 2, Movicol 1 (on demand), Mycophenolate mofetil 2 × 500 mg, Tacrolimus 2 × 1 mg and Hydrochlorothiazid 1 × 2.5 mg. 3) Additional diagnoses included arterial hypertension, diabetes mellitus and urinary bladder diverticle. 4) Previous surgical intervention profile comprises resection of liver segments IV/V due to HCC (2011), orthotopic liver transplantation because of HCC caused by alcohol-induced liver cirrhosis (2013) and an intervertebral disc operation (2018). Physical examination of the abdomen revealed marked tenderness in the lower left quadrant. The abdominal wall was soft and there were no defensive tension and no peritonism. The patient was in good general condition and nutritional status. He was cardiopulmonarily stable and oriented to all qualities. Diagnostic measures showed a CRP of 38.0 (normal range, &lt; 5) mg/L and a white blood cell count within normal range. Leading diagnoses were found using abdominal CT scan, which demonstrated an extended diverticulosis and an appendicitis epiploica within the immediate subperitoneal region of the left lower abdomen with an oval fat isodense structure in the region of the sigmoid colon with surrounding inflammatory imbibition and pronounced intestinal wall. Suspicious diagnosis was the 1st episode of an uncomplicated diverticulitis of the sigmoid colon associated with an appendicitis epiploica. Therapeutic approach was given by conservative therapy with infusion therapy, analgesia as well as inital “n. p. o.” and following initiation of oral nutrition. In addition, calculated antibiotic therapy with Cefuroxime and Clont was initiated. Clinical course was uneventful, with discharge on the eighth day of hospital stay with no pathological findings and substantial improvement in clinical and laboratory findings. Further advice consisted of clinical and laboratory follow-up control investigations by the family practitioner and nutritional counselling. In addition, a colonoscopy should be performed within four months. Co","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"184 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135353913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resection rectopexy as part of the multidisciplinary approach in the management of complex pelvic floor disorders. 切除直肠固定术是治疗复杂盆底疾病的多学科方法的一部分。
IF 1.3 Q2 SURGERY Pub Date : 2023-07-31 eCollection Date: 2023-03-01 DOI: 10.1515/iss-2022-0027
Georgi Kalev, Christoph Marquardt, Marten Schmerer, Anja Ulrich, Wolfgang Heyl, Thomas Schiedeck

Objectives: Pelvic floor disorders are frequently caused by an organ prolapse involving multiple pelvic floor compartments. In such cases, a multidisciplinary strategy for diagnostic work-up and therapy is required.

Methods: All patients who underwent transabdominal rectopexy/resection rectopexy alone or in combination with simultaneous gynecological pelvic floor reconstruction at our institution between 01/2006 and 12/2021 were included in this retrospective study. The study aimed to evaluate the functional outcome and postoperative complications.

Results: Two hundred and eighty seven patients were assigned to one of the following groups: PG1 - patient group one: after resection rectopexy (n=141); PG2 - after ventral rectopexy (n=8); PG3 - after combined resection rectopexy and sacro (cervico)colpopexy (n=62); PG4 - after combined resection rectopexy and trans-vaginal pelvic floor repair (n=76). The duration of follow-up was 14 months for PG1 (median, IQR 37 months), 11 months for PG2 (mean, SD 9 months), 7 months for PG 3 (median, IQR 33 months), and 12 months for PG 4 (median, IQR 51 Months). The surgical procedure resulted in improvement of symptoms related to obstructed defecation in 56.4 % (22/39) of the patients in PG1, 25 % in PG2 (1/4), 62.5 % (20/32) in PG3, and 71.8 % (28/39) in PG4. "De novo" constipation was reported by 2.4 % (2/141) of patients from PG1. Improvement in fecal incontinence symptoms was reported by 69 % (40/58) of patients in PG1, 100 % in PG2 (2/2), 93.1 % (27/29) in PG3, and 87.2 % (34/39) in PG4. The recurrence rate for external rectal prolapse was 7.1 % in PG1, 50 % in PG2 (1/2), 2.7 % in PG3, and 6.3 % in PG4. A significant difference in terms of severe morbidity (grade ≥ IIIb) and mortality could not be determined between the non-interdisciplinary (PG1 with PG2) and interdisciplinary surgery (PG3 with PG4) (p=0.88, p=0.499).

Conclusions: Based on our results, we can assume that combined surgery is as feasible as rectal surgery alone. In our study, combined interventions were effective and not associated with an increased risk of postoperative complications.

目的:盆底疾病通常是由涉及多个盆底隔间的器官脱垂引起的。在这种情况下,需要采用多学科的诊断检查和治疗策略。方法:本回顾性研究纳入了2006年1月至2021年12月期间在我院单独或同时进行妇科盆底重建的所有患者。本研究旨在评估功能结果和术后并发症。结果:287例患者被分为以下组之一:PG1-患者第一组:切除后直肠固定术(n=141);PG2-腹侧直肠固定术后(n=8);PG3-直肠固定和骶(颈)阴道联合切除术后(n=62);PG4-联合切除直肠固定术和经阴道盆底修复术后(n=76)。PG1的随访时间为14个月(中位数,IQR 37个月),PG2为11个月(平均,SD 9个月)、PG3为7个月(中值,IQR 33个月)和PG4为12个月(中点,IQR 51 月份)。手术治疗改善了56.4例排便障碍相关症状 % (22/39)PG1患者,25 % PG2(1/4),62.5 % PG3中的(20/32)和71.8 % (28/39)在PG4中。2.4 % (2/141)PG1患者。69人报告大便失禁症状有所改善 % (40/58)PG1100患者 % PG2(2/2),93.1 % PG3中的(27/29)和87.2 % (34/39)。直肠外脱垂的复发率为7.1 % 在PG1中,50 % 在PG2(1/2)中,2.7 % PG3和6.3 % 在PG4中。非跨学科(PG1与PG2)和跨学科手术(PG3与PG4)在严重发病率(≥IIIb级)和死亡率方面无法确定显著差异(p=0.88,p=0.499)。结论:根据我们的结果,我们可以假设联合手术与单独直肠手术一样可行。在我们的研究中,联合干预是有效的,并且与术后并发症的风险增加无关。
{"title":"Resection rectopexy as part of the multidisciplinary approach in the management of complex pelvic floor disorders.","authors":"Georgi Kalev,&nbsp;Christoph Marquardt,&nbsp;Marten Schmerer,&nbsp;Anja Ulrich,&nbsp;Wolfgang Heyl,&nbsp;Thomas Schiedeck","doi":"10.1515/iss-2022-0027","DOIUrl":"10.1515/iss-2022-0027","url":null,"abstract":"<p><strong>Objectives: </strong>Pelvic floor disorders are frequently caused by an organ prolapse involving multiple pelvic floor compartments. In such cases, a multidisciplinary strategy for diagnostic work-up and therapy is required.</p><p><strong>Methods: </strong>All patients who underwent transabdominal rectopexy/resection rectopexy alone or in combination with simultaneous gynecological pelvic floor reconstruction at our institution between 01/2006 and 12/2021 were included in this retrospective study. The study aimed to evaluate the functional outcome and postoperative complications.</p><p><strong>Results: </strong>Two hundred and eighty seven patients were assigned to one of the following groups: PG1 - patient group one: after resection rectopexy (n=141); PG2 - after ventral rectopexy (n=8); PG3 - after combined resection rectopexy and sacro (cervico)colpopexy (n=62); PG4 - after combined resection rectopexy and <i>trans</i>-vaginal pelvic floor repair (n=76). The duration of follow-up was 14 months for PG1 (median, IQR 37 months), 11 months for PG2 (mean, SD 9 months), 7 months for PG 3 (median, IQR 33 months), and 12 months for PG 4 (median, IQR 51 Months). The surgical procedure resulted in improvement of symptoms related to obstructed defecation in 56.4 % (22/39) of the patients in PG1, 25 % in PG2 (1/4), 62.5 % (20/32) in PG3, and 71.8 % (28/39) in PG4. \"<i>De novo</i>\" constipation was reported by 2.4 % (2/141) of patients from PG1. Improvement in fecal incontinence symptoms was reported by 69 % (40/58) of patients in PG1, 100 % in PG2 (2/2), 93.1 % (27/29) in PG3, and 87.2 % (34/39) in PG4. The recurrence rate for external rectal prolapse was 7.1 % in PG1, 50 % in PG2 (1/2), 2.7 % in PG3, and 6.3 % in PG4. A significant difference in terms of severe morbidity (grade ≥ IIIb) and mortality could not be determined between the non-interdisciplinary (PG1 with PG2) and interdisciplinary surgery (PG3 with PG4) (p=0.88, p=0.499).</p><p><strong>Conclusions: </strong>Based on our results, we can assume that combined surgery is as feasible as rectal surgery alone. In our study, combined interventions were effective and not associated with an increased risk of postoperative complications.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"8 1","pages":"29-36"},"PeriodicalIF":1.3,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact factor for Innovative Surgical Sciences - heading for the future. 创新外科科学的影响因素-走向未来。
IF 1.3 Q2 SURGERY Pub Date : 2023-07-27 eCollection Date: 2023-03-01 DOI: 10.1515/iss-2023-2001
Joachim Jaehne
Innovative Surgical Sciences, founded as Gold Open Access Journal by the German Society of Surgery in 2016 [1, 2], was just recently informed by Clarivate Analytics that the journal gained an impact factor of 1.3. The German Society of Surgery and the publisher DeGruyter would like to thank all members of the Editorial Board, all authors and their coworkers aswell as all reviewers for their continuous support of the journal. Without these efforts and the constant dedication to the journal, such a success after a relatively short period following the launch of the journal in 2016would not have been possible – thank you very much! Additionally, gaining an impact factor as an open access journal shows that open access has become a wellestablished publication method. More and more originally pure print journals with very high reputation switch to open access formats [3, 4]. Open access will most likely substitute the “old-fashioned” printed journals and will represent the standard of scientific communication in the very near future [4]. Now, that the impact factor is reality, one could say: mission accomplished! Although the impact factor was one aim to achieve, it needs to be said that this is just the beginning! The impact factor encourages to put even more effort in the aim to fully establish the journal within the surgical scientific community. In the last years the journal experienced some changes which seemed to be relevant and necessary. The layout was changed from green to blue to fulfill the requirements for a consequent marketing strategy of the German Society of Surgery, which also changed the color. Furthermore, all abstracts of the congress of the German Society of Surgery were published open access as a supplement to the journal so that the congress and the abstracts reach a wide surgical community. To fully support the various surgical societies which are members of the German Society of Surgery a National Editorial Board was established. This board should result in a greater participation of all surgical subspecialties in designing the content and the articles published in Innovative Surgical Sciences. Since the launch in 2016 Innovative Surgical Sciences is listed in all relevant data bases, and the journal has been in Pubmed for some years which may also be another reason for gaining the impact factor. Additionally, the actual Scopus Cite Score is 4.5, so that we feel that our road map for the future is correct. In comparison to other journals, one issue which we strictly follow is the publication of all reviews of the double-blind-review process. To our feeling, this is essential for the transparency of scientific communication, and it is the unique selling point of Innovative Surgical Sciences. Hereby, we also can communicate a rejection rate of 52 % for the years 2021 and 2022. Our aim for the years to come is clearly defined to further increase the impact factor. This aimmay be achieved by a broader internationalization of the j
{"title":"Impact factor for Innovative Surgical Sciences - heading for the future.","authors":"Joachim Jaehne","doi":"10.1515/iss-2023-2001","DOIUrl":"10.1515/iss-2023-2001","url":null,"abstract":"Innovative Surgical Sciences, founded as Gold Open Access Journal by the German Society of Surgery in 2016 [1, 2], was just recently informed by Clarivate Analytics that the journal gained an impact factor of 1.3. The German Society of Surgery and the publisher DeGruyter would like to thank all members of the Editorial Board, all authors and their coworkers aswell as all reviewers for their continuous support of the journal. Without these efforts and the constant dedication to the journal, such a success after a relatively short period following the launch of the journal in 2016would not have been possible – thank you very much! Additionally, gaining an impact factor as an open access journal shows that open access has become a wellestablished publication method. More and more originally pure print journals with very high reputation switch to open access formats [3, 4]. Open access will most likely substitute the “old-fashioned” printed journals and will represent the standard of scientific communication in the very near future [4]. Now, that the impact factor is reality, one could say: mission accomplished! Although the impact factor was one aim to achieve, it needs to be said that this is just the beginning! The impact factor encourages to put even more effort in the aim to fully establish the journal within the surgical scientific community. In the last years the journal experienced some changes which seemed to be relevant and necessary. The layout was changed from green to blue to fulfill the requirements for a consequent marketing strategy of the German Society of Surgery, which also changed the color. Furthermore, all abstracts of the congress of the German Society of Surgery were published open access as a supplement to the journal so that the congress and the abstracts reach a wide surgical community. To fully support the various surgical societies which are members of the German Society of Surgery a National Editorial Board was established. This board should result in a greater participation of all surgical subspecialties in designing the content and the articles published in Innovative Surgical Sciences. Since the launch in 2016 Innovative Surgical Sciences is listed in all relevant data bases, and the journal has been in Pubmed for some years which may also be another reason for gaining the impact factor. Additionally, the actual Scopus Cite Score is 4.5, so that we feel that our road map for the future is correct. In comparison to other journals, one issue which we strictly follow is the publication of all reviews of the double-blind-review process. To our feeling, this is essential for the transparency of scientific communication, and it is the unique selling point of Innovative Surgical Sciences. Hereby, we also can communicate a rejection rate of 52 % for the years 2021 and 2022. Our aim for the years to come is clearly defined to further increase the impact factor. This aimmay be achieved by a broader internationalization of the j","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"8 1","pages":"1"},"PeriodicalIF":1.3,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracapsular extension of pN2 lymph node metastases is not prognostically significant in surgically resected patients with non-small cell lung cancer. pN2淋巴结转移的囊外延伸在外科切除的癌症非小细胞肺癌患者中没有预后意义。
IF 1.3 Q2 SURGERY Pub Date : 2023-05-04 eCollection Date: 2023-03-01 DOI: 10.1515/iss-2022-0023
Christin Müller, Samantha Taber, Joachim Pfannschmidt, Sergej Griff

Objectives: In patients with non-small cell lung cancer (NSCLC) the pathologic lymph node status N2 is a heterogeneous entity, with different degrees of lymph node involvement representing different prognoses. It is speculated whether extra capsular nodal extension may help to define a subgroup with implications on long-term survival.

Methods: We retrospectively identified 118 patients with non-small cell lung cancer (65 men, 53 women), who were treated between 2013 and 2018 and found to have pathologic N2 lymph node involvement. In all patients lung resection with systematic mediastinal and hilar lymph node dissection was performed with curative intent. In N2 lymph node metastases capsules of affected lymph nodes were examined microscopically as to whether extracapsular extension was present.

Results: 51 patients (43 %) had extracapsular extension (ENE). Most of these patients (n=35) only had ENE in a single lymph node (69 %). The overall 5-year survival rate was 24.6 % and progression-free survival rate 17.8 %. In the multivariate analysis OS was worse for patients with multiple affected pN2 stations, concurrent N1 metastases, increasing age, and larger tumor size. For the percentage of lymph nodes affected with ENE (of total examined) only a non-significant trend towards worse OS could be observed (p=0.06).

Conclusions: Although we could not demonstrate significant prognostic differences between N2 extra capsular nodal involvement within our patient population, other analyses may yield different results. However, clinicians should continue performing thorough lymph nodes dissections in order to achieve local complete resection even in patients with extra capsular tumor spread.

目的:在癌症(NSCLC)患者中,病理性淋巴结状态N2是一个异质性实体,不同程度的淋巴结受累代表不同的预后。据推测,包膜外淋巴结的扩展是否有助于确定一个对长期生存有影响的亚组。方法:我们回顾性确定了118例癌症患者(65名男性,53名女性),他们在2013年至2018年间接受了治疗,发现病理性N2淋巴结受累。所有患者都进行了肺切除术,并进行了系统的纵隔和肺门淋巴结清扫,以达到治疗目的。在N2淋巴结转移中,用显微镜检查受影响淋巴结的包膜是否存在包膜外延伸。结果:51名患者(43名 %) 具有囊外延伸(ENE)。这些患者中的大多数(n=35)仅在单个淋巴结中有ENE(69 %). 总的5年生存率为24.6 % 无进展生存率17.8 %. 在多变量分析中,多个受影响的pN2位点、同时有N1转移、年龄增加和肿瘤大小较大的患者的OS更差。对于受ENE影响的淋巴结百分比(占检查总数),只能观察到OS恶化的非显著趋势(p=0.06)。结论:尽管我们不能证明N2包膜外淋巴结在我们的患者群体中存在显著的预后差异,但其他分析可能会产生不同的结果。然而,临床医生应该继续进行彻底的淋巴结解剖,以实现局部完全切除,即使是囊外肿瘤扩散的患者。
{"title":"Extracapsular extension of pN2 lymph node metastases is not prognostically significant in surgically resected patients with non-small cell lung cancer.","authors":"Christin Müller,&nbsp;Samantha Taber,&nbsp;Joachim Pfannschmidt,&nbsp;Sergej Griff","doi":"10.1515/iss-2022-0023","DOIUrl":"10.1515/iss-2022-0023","url":null,"abstract":"<p><strong>Objectives: </strong>In patients with non-small cell lung cancer (NSCLC) the pathologic lymph node status N2 is a heterogeneous entity, with different degrees of lymph node involvement representing different prognoses. It is speculated whether extra capsular nodal extension may help to define a subgroup with implications on long-term survival.</p><p><strong>Methods: </strong>We retrospectively identified 118 patients with non-small cell lung cancer (65 men, 53 women), who were treated between 2013 and 2018 and found to have pathologic N2 lymph node involvement. In all patients lung resection with systematic mediastinal and hilar lymph node dissection was performed with curative intent. In N2 lymph node metastases capsules of affected lymph nodes were examined microscopically as to whether extracapsular extension was present.</p><p><strong>Results: </strong>51 patients (43 %) had extracapsular extension (ENE). Most of these patients (n=35) only had ENE in a single lymph node (69 %). The overall 5-year survival rate was 24.6 % and progression-free survival rate 17.8 %. In the multivariate analysis OS was worse for patients with multiple affected pN2 stations, concurrent N1 metastases, increasing age, and larger tumor size. For the percentage of lymph nodes affected with ENE (of total examined) only a non-significant trend towards worse OS could be observed (p=0.06).</p><p><strong>Conclusions: </strong>Although we could not demonstrate significant prognostic differences between N2 extra capsular nodal involvement within our patient population, other analyses may yield different results. However, clinicians should continue performing thorough lymph nodes dissections in order to achieve local complete resection even in patients with extra capsular tumor spread.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"8 1","pages":"9-16"},"PeriodicalIF":1.3,"publicationDate":"2023-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Female physician and pregnancy- effect of the amended German maternity protection act on female doctors' careers. 女医生和怀孕——修订后的德国《产妇保护法》对女医生职业生涯的影响。
IF 1.3 Q2 SURGERY Pub Date : 2023-03-31 eCollection Date: 2023-03-01 DOI: 10.1515/iss-2022-0024
Barbara Puhahn-Schmeiser, Eva K Hennel, Christiane Gross, Heike Raestrup, Astrid Bühren, Mandy Mangler

Objectives: In Germany, the 2018 amended Maternity Protection Act frequently leads to fundamental restrictions for female physicians, especially surgeons, and now even also for students impeding the progress of their careers. Our goal was to assess the current situation for pregnant female physicians and students, respectively, and their perspective on this amendment regarding their career path.

Methods: A nationwide survey was conducted in Germany from December 2020 to February 2021. The questionnaire included 790 female physicians and students who were pregnant after the inception of the amended Act. Those women pregnant after the beginning of the corona pandemic were excluded.

Results: The survey revealed that two thirds of female physicians worked a maximum of 50% in their previous professional activity as soon as they reported pregnancy. Amongst medical students this amounted up to 72%. 18% of the female physicians and 17% of the female medical students respectively could not follow the sense of these restrictions. 44% of female medical physicians and 33% of female students felt their career impeded. This led up to 43% amongst female medical doctors and 53% amongst female medical students, respectively, who were concerned to announce their pregnancy. As a consequence, pregnancies were reported at 12 weeks in female physicians compared to 19 weeks in medical students.

Conclusions: Analyses of the current survey revealed that a relevant number of female physicians and medical students felt impeded in their career path through the application of the amended Maternity Act.

目标:在德国,2018年修订的《产妇保护法》经常导致对女医生,尤其是外科医生的根本限制,现在甚至对阻碍职业发展的学生也有限制。我们的目标是分别评估怀孕女医生和学生的现状,以及她们对这项修正案的看法。方法:2020年12月至2021年2月在德国进行了一项全国性调查。调查问卷包括790名女医生和学生,她们在修正法案生效后怀孕。那些在新冠疫情开始后怀孕的妇女被排除在外。结果:调查显示,三分之二的女医生在报告怀孕后,在之前的专业活动中最多工作了50%。在医学生中,这一比例高达72%。18%的女医生和17%的女医学生不能理解这些限制。44%的女医生和33%的女学生认为自己的职业生涯受到阻碍。这导致关注宣布怀孕的女医生和女医学生分别占43%和53%。因此,据报道,女医生怀孕12周,而医学生怀孕19周。结论:对当前调查的分析显示,通过实施修订后的《产妇法》,相关数量的女医生和医学生在职业道路上感到受到阻碍。
{"title":"Female physician and pregnancy- effect of the amended German maternity protection act on female doctors' careers.","authors":"Barbara Puhahn-Schmeiser,&nbsp;Eva K Hennel,&nbsp;Christiane Gross,&nbsp;Heike Raestrup,&nbsp;Astrid Bühren,&nbsp;Mandy Mangler","doi":"10.1515/iss-2022-0024","DOIUrl":"10.1515/iss-2022-0024","url":null,"abstract":"<p><strong>Objectives: </strong>In Germany, the 2018 amended Maternity Protection Act frequently leads to fundamental restrictions for female physicians, especially surgeons, and now even also for students impeding the progress of their careers. Our goal was to assess the current situation for pregnant female physicians and students, respectively, and their perspective on this amendment regarding their career path.</p><p><strong>Methods: </strong>A nationwide survey was conducted in Germany from December 2020 to February 2021. The questionnaire included 790 female physicians and students who were pregnant after the inception of the amended Act. Those women pregnant after the beginning of the corona pandemic were excluded.</p><p><strong>Results: </strong>The survey revealed that two thirds of female physicians worked a maximum of 50% in their previous professional activity as soon as they reported pregnancy. Amongst medical students this amounted up to 72%. 18% of the female physicians and 17% of the female medical students respectively could not follow the sense of these restrictions. 44% of female medical physicians and 33% of female students felt their career impeded. This led up to 43% amongst female medical doctors and 53% amongst female medical students, respectively, who were concerned to announce their pregnancy. As a consequence, pregnancies were reported at 12 weeks in female physicians compared to 19 weeks in medical students.</p><p><strong>Conclusions: </strong>Analyses of the current survey revealed that a relevant number of female physicians and medical students felt impeded in their career path through the application of the amended Maternity Act.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"8 1","pages":"23-28"},"PeriodicalIF":1.3,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Presentation, management and outcomes of iliopsoas abscess at a University Teaching Hospital in Nepal. 尼泊尔一所大学教学医院髂腰肌脓肿的介绍、治疗和结果。
IF 1.3 Q2 SURGERY Pub Date : 2023-03-27 eCollection Date: 2023-03-01 DOI: 10.1515/iss-2022-0013
Jayant Kumar Sah, Shankar Adhikari, Ganesh Sah, Bikal Ghimire, Yogendra Prasad Singh

Objectives: Iliopsoas abscess (IPA) is an uncommon clinical disease and is often missed to diagnose due to vague clinical presentation. Early treatment with drainage and appropriate antibiotic therapy is necessary before sepsis sets in and become lethal. We conducted this study to evaluate clinical features, etiology, management strategies, and outcomes in patients with IPA from a University Teaching Hospital in Nepal.

Methods: A retrospective analysis of 32 consecutive IPA cases managed at Tribhuvan University Teaching Hospital, Nepal for the period of January 2019 to February 2022 was carried out.

Results: The mean age was 42.5 ± 19.1 years (range, 19-75 years) and the male: female ratio was 2.2:1. Two-thirds or more patients presented with fever, limp, fixed flexion deformity and/or low back pain. Ultrasonography (US) was diagnostic in 27 (84.4%) patients. Eighteen (56.3%) patients had primary IPAs, and 14 (43.7%) had secondary IPAs. Thirty (93.7%) patients were managed with US guided percutaneous drainage (PCD) and 2 (6.2%) patients underwent open surgical drainage. Drainage procedures were combined with antibiotics in all patients. Pus culture showed Staphylococcus aureus growing in the majority of cases (10 of 23, 43.5%). The hospital stay was longer in patients treated via surgical drainage compared to those who received PCD: 13 days (range 12-14 days) vs. 6.6 days (range 4-13 days), respectively. Recurrence of abscess was seen in 4 (12.5%) cases and all were successfully managed via a second PCD. There was no mortality.

Conclusions: Varying clinical presentation of iliopsoas abscess demand a high index of suspicion for early diagnosis. Initial imaging modality in suspected case of IPA is US. US-guided PCD along with the appropriate antibiotics is a successful frontline treatment of IPAs with shorter hospital stay.

目的:髂腰肌脓肿(IPA)是一种不常见的临床疾病,由于临床表现模糊,常被漏诊。在败血症发作并致命之前,早期引流和适当的抗生素治疗是必要的。我们进行了这项研究,以评估尼泊尔一所大学教学医院IPA患者的临床特征、病因、管理策略和结果。方法:对2019年1月至2022年2月期间在尼泊尔特里布万大学教学医院管理的32例连续IPA病例进行回顾性分析。结果:平均年龄为42.5±19.1岁(19~75岁),男女比例为2.2:1。三分之二或更多的患者出现发烧、跛行、固定屈曲畸形和/或腰痛。超声诊断27例(84.4%)。18名(56.3%)患者患有原发性IPA,14名(43.7%)患者患有继发性IPA。30名(93.7%)患者接受了US引导的经皮穿刺引流术(PCD),2名(6.2%)患者接受开放手术引流。所有患者均采用引流术和抗生素治疗。Pus培养显示,大多数病例(23例中有10例,43.5%)中都有金黄色葡萄球菌生长。与接受PCD的患者相比,通过手术引流治疗的患者住院时间更长:分别为13天(12-14天)和6.6天(4-13天)。脓肿复发4例(12.5%),均通过第二次PCD成功治疗。没有死亡。结论:髂腰肌脓肿的不同临床表现要求早期诊断具有较高的怀疑指数。疑似IPA病例的初始成像模式是美国。美国指导的PCD和适当的抗生素是IPA的成功一线治疗,住院时间更短。
{"title":"Presentation, management and outcomes of iliopsoas abscess at a University Teaching Hospital in Nepal.","authors":"Jayant Kumar Sah,&nbsp;Shankar Adhikari,&nbsp;Ganesh Sah,&nbsp;Bikal Ghimire,&nbsp;Yogendra Prasad Singh","doi":"10.1515/iss-2022-0013","DOIUrl":"10.1515/iss-2022-0013","url":null,"abstract":"<p><strong>Objectives: </strong>Iliopsoas abscess (IPA) is an uncommon clinical disease and is often missed to diagnose due to vague clinical presentation. Early treatment with drainage and appropriate antibiotic therapy is necessary before sepsis sets in and become lethal. We conducted this study to evaluate clinical features, etiology, management strategies, and outcomes in patients with IPA from a University Teaching Hospital in Nepal.</p><p><strong>Methods: </strong>A retrospective analysis of 32 consecutive IPA cases managed at Tribhuvan University Teaching Hospital, Nepal for the period of January 2019 to February 2022 was carried out.</p><p><strong>Results: </strong>The mean age was 42.5 ± 19.1 years (range, 19-75 years) and the male: female ratio was 2.2:1. Two-thirds or more patients presented with fever, limp, fixed flexion deformity and/or low back pain. Ultrasonography (US) was diagnostic in 27 (84.4%) patients. Eighteen (56.3%) patients had primary IPAs, and 14 (43.7%) had secondary IPAs. Thirty (93.7%) patients were managed with US guided percutaneous drainage (PCD) and 2 (6.2%) patients underwent open surgical drainage. Drainage procedures were combined with antibiotics in all patients. Pus culture showed <i>Staphylococcus aureus</i> growing in the majority of cases (10 of 23, 43.5%). The hospital stay was longer in patients treated via surgical drainage compared to those who received PCD: 13 days (range 12-14 days) vs. 6.6 days (range 4-13 days), respectively. Recurrence of abscess was seen in 4 (12.5%) cases and all were successfully managed via a second PCD. There was no mortality.</p><p><strong>Conclusions: </strong>Varying clinical presentation of iliopsoas abscess demand a high index of suspicion for early diagnosis. Initial imaging modality in suspected case of IPA is US. US-guided PCD along with the appropriate antibiotics is a successful frontline treatment of IPAs with shorter hospital stay.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"8 1","pages":"17-22"},"PeriodicalIF":1.3,"publicationDate":"2023-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract DGKCH 文摘DGKCH
IF 1.3 Q2 SURGERY Pub Date : 2023-03-01 DOI: 10.1515/iss-2023-9008
{"title":"Abstract DGKCH","authors":"","doi":"10.1515/iss-2023-9008","DOIUrl":"https://doi.org/10.1515/iss-2023-9008","url":null,"abstract":"","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"7 3 1","pages":"148 - 215"},"PeriodicalIF":1.3,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77404350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract DGAV 文摘DGAV
IF 1.3 Q2 SURGERY Pub Date : 2023-03-01 DOI: 10.1515/iss-2023-9004
{"title":"Abstract DGAV","authors":"","doi":"10.1515/iss-2023-9004","DOIUrl":"https://doi.org/10.1515/iss-2023-9004","url":null,"abstract":"","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"19 1","pages":"31 - 122"},"PeriodicalIF":1.3,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80772105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract DGG 文摘DGG
IF 1.3 Q2 SURGERY Pub Date : 2023-03-01 DOI: 10.1515/iss-2023-9006
P. Donndorf, J. Gross, Peter Ouvrier, Clemens Schafmayer
myotomy
肌切开术
{"title":"Abstract DGG","authors":"P. Donndorf, J. Gross, Peter Ouvrier, Clemens Schafmayer","doi":"10.1515/iss-2023-9006","DOIUrl":"https://doi.org/10.1515/iss-2023-9006","url":null,"abstract":"myotomy","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"5 1","pages":"129 - 136"},"PeriodicalIF":1.3,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82558003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract DGT 摘要分析我国
Q2 SURGERY Pub Date : 2023-03-01 DOI: 10.1515/iss-2023-9001
{"title":"Abstract DGT","authors":"","doi":"10.1515/iss-2023-9001","DOIUrl":"https://doi.org/10.1515/iss-2023-9001","url":null,"abstract":"","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134950115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Innovative Surgical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1